IDEX Biometrics ASA: Mandatory notification of subscription by primary insider – 2 Dec 2024

GlobeNewswire
2024-12-02

Reference is made to the subsequent offering in IDEX Biometrics ASA (the “Company”) approved by the Extraordinary General Meeting on 9 October 2024.

The Company’s Chair, Morten Opstad, has subscribed to 1,000,000 shares, at NOK 0.15 per share. Whereof he subscribed to 250,000 shares for K-Konsult AS, and 750,000 shares for Marc O Polo Norge AS. The final allocation, including the primary insider registration form, will be notified later today.

For further information contact:
Marianne Bøe, Head of Investor Relations
Kristian Flaten, CFO
E-mail: ir@idexbiometrics.com
Tel: + 47 67 83 91 19



About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

This notice was issued by Marianne Bøe, Head of Investor Relations, on 2 December November 2024 at 08:55 CET on behalf of IDEX Biometrics ASA.


免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10